Intra-Individual Changes in Total Procollagen-Type 1 N-terminal Propeptide in a Korean Adult Population

We aimed to investigate intra-individual changes in total procollagen-type 1 N-terminal pro-peptide (P1NP), a biochemical marker of bone turnover, to understand patient populations and test utilization in a Korean adult population while considering different definitions of least significant changes by sex, age, and medical institution type. Overall, 31,501 P1NP tests were performed on 24,644 Korean adults (3389 men and 21,255 women) with a median age of 68.9 years (interquartile range, IQR, 61.2-77.2) for osteoporosis evaluation. Among these, 1331 (5.4%) patients (127 men and 1204 women) underwent >= 3 follow-up P1NP measurements. The median follow-up period was 12.5 months (IQR, 11.7-15.9). Among 1331 patients, 64.4% experienced a decrease in P1NP and 35.6% experienced an increase in P1NP during follow-up. Among these, the proportion of patients who experienced serum P1NP changes >= 14.4% from baseline was 92.3%, and the proportion of patients who achieved <= 40 ng/mL (a median level of premenopausal Korean women) during follow-up was 31.8%. The overall proportion of patients that experienced a serum P1NP change exceeding the least significant change during follow-up was not significantly different by the type of medical institution.

Automated summary

This study aimed to investigate intra-individual changes in total procollagen-type 1 N-terminal pro-peptide (P1NP) in a Korean adult population, providing insights into patient populations and test utilization. The findings showed that majority of patients experienced a decrease in P1NP during follow-up, while a smaller proportion had an increase. Furthermore, the type of medical institution did not significantly influence the change in P1NP during follow-up.